ANGELA PHAM: Open Payments
NPI 1316631963 · GLENSIDE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,436 in 83 payments from 17 companies in 2025. Trend: 2023 $56 · 2024 $130 · 2025 $2,436
Food & beverage: $2,330Education: $106
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 28 | $995 |
| Sumitomo Pharma America, Inc. | 16 | $272 |
| Merck Sharp & Dohme LLC | 6 | $250 |
| Bayer Healthcare Pharmaceuticals Inc. | 11 | $214 |
| Procept Biorobotics Corporation | 1 | $127 |
| Telix Pharmaceuticals | 2 | $112 |
| Astellas Pharma US Inc | 1 | $98 |
| ACCORD HEALTHCARE, INC. | 4 | $77 |
| PFIZER INC. | 3 | $67 |
| Dendreon Pharmaceuticals LLC | 2 | $55 |
Products named: ERLEADA, RYBREVANT, ORGOVYX, KEYTRUDA, Nubeqa, AQUABEAM ROBOTIC SYSTEM, ILLUCCIX, Camcevi.
Industry payments across PA — which companies pay providers there.
